Drug Profile
Allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen dsat - Stratatech
Alternative Names: Allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen- dsat; Human skin replacement - Stratatech; SOMA Tx - Stratatech; StrataGraft; StrataGraft Overlay of Meshed Autograft - StratatechLatest Information Update: 16 Apr 2024
Price :
$50
*
At a glance
- Originator University of Wisconsin System; Wisconsin Alumni Research Foundation
- Developer Stratatech
- Class Cell therapies
- Mechanism of Action Tissue replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Registered Burns
- Discontinued Wounds
Most Recent Events
- 04 Jan 2024 Allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen dsat is available for licensing as of 04 Jan 2024. https://www.mallinckrodt.com/contact-us/
- 05 Sep 2023 Mallinckrodt receives US FDA label update for StrataGraft® (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen – dsat) to reduce xenotransplantation requirements
- 30 Dec 2022 Mallinckrodt Pharmaceuticals has patent protection for StrataGraft® in USA